2020
Effect of Time to Surgery of Colorectal Liver Metastases on Survival
Chen EY, Mayo SC, Sutton T, Kearney MR, Kardosh A, Vaccaro GM, Billingsley KG, Lopez CD. Effect of Time to Surgery of Colorectal Liver Metastases on Survival. Journal Of Gastrointestinal Cancer 2020, 52: 169-176. PMID: 32086781, PMCID: PMC7900034, DOI: 10.1007/s12029-020-00372-5.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantColorectal NeoplasmsDisease-Free SurvivalFemaleFollow-Up StudiesHepatectomyHumansKaplan-Meier EstimateLiver NeoplasmsMaleMiddle AgedNeoadjuvant TherapyNeoplasm Recurrence, LocalPrognosisRetrospective StudiesTime FactorsTime-to-TreatmentYoung AdultConceptsColorectal liver metastasesLong-term OSPostoperative overall survivalOverall survivalLonger TTSLiver metastasesWorse survivalDiagnosis of CLMLong-term survivorsResultsTwo hundred eightyRisk of recurrenceComprehensive cancer centerHigh disease burdenSpecific primary tumorsShorter TTSPerioperative chemotherapyPostoperative chemotherapyPerioperative treatmentResection marginsCancer CenterMetastasis characteristicsInstitutional databasePrimary tumorDisease burdenSimilar survival
2019
Who Undergoes Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Appendiceal Cancer? An Analysis of the National Cancer Database
Byrne RM, Gilbert EW, Dewey EN, Herzig DO, Lu KC, Billingsley KG, Deveney KE, Tsikitis VL. Who Undergoes Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Appendiceal Cancer? An Analysis of the National Cancer Database. Journal Of Surgical Research 2019, 238: 198-206. PMID: 30772678, DOI: 10.1016/j.jss.2019.01.039.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsAppendiceal NeoplasmsChemotherapy, AdjuvantChemotherapy, Cancer, Regional PerfusionCytoreduction Surgical ProceduresDatabases, FactualFemaleHumansHyperthermia, InducedKaplan-Meier EstimateMaleMiddle AgedNeoadjuvant TherapyRetrospective StudiesSex FactorsTreatment OutcomeUnited StatesConceptsPerioperative intraperitoneal chemotherapyAppendiceal cancerCytoreductive surgeryIntraperitoneal chemotherapyTreatment modalitiesNational Cancer Database dataMultivariate logistic regression analysisNational Cancer DatabasePatterns of careLow-grade tumorsNon-Hispanic ethnicityLogistic regression analysisMucinous malignanciesSystemic chemotherapyMultimodality treatmentClinical factorsImproved survivalPatient selectionMale sexKaplan-MeierPatient cohortCancer DatabaseWhite raceTreatment groupsChemotherapy
2017
Cetuximab Combined With Induction Oxaliplatin and Capecitabine, Followed by Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: SWOG 0713
Leichman CG, McDonough SL, Smalley SR, Billingsley KG, Lenz HJ, Beldner MA, Hezel AF, Velasco MR, Guthrie KA, Blanke CD, Hochster HS. Cetuximab Combined With Induction Oxaliplatin and Capecitabine, Followed by Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: SWOG 0713. Clinical Colorectal Cancer 2017, 17: e121-e125. PMID: 29233486, PMCID: PMC6598683, DOI: 10.1016/j.clcc.2017.10.008.Peer-Reviewed Original ResearchConceptsPathologic complete responseAdvanced rectal cancerNeoadjuvant chemoradiationRectal cancerInduction chemotherapyKRAS wild-type metastatic colorectal cancerWild-type metastatic colorectal cancerThree-year disease-free survivalLocally Advanced Rectal CancerMetastatic colorectal cancerDisease-free survivalPhase III trialsAdequate hematologicEligible patientsBowel obstructionSame regimenIII trialsPerformance statusRenal functionComplete responseImproved survivalClinical outcomesMicroscopic cancerRectal adenocarcinomaPatient eligibility
2010
Techniques and results of portal vein/superior mesenteric vein reconstruction using femoral and saphenous vein during pancreaticoduodenectomy
Lee D, Mitchell E, Jones M, Landry G, Liem T, Sheppard B, Billingsley K, Moneta G. Techniques and results of portal vein/superior mesenteric vein reconstruction using femoral and saphenous vein during pancreaticoduodenectomy. Journal Of Vascular Surgery 2010, 51: 662-666. PMID: 20080375, DOI: 10.1016/j.jvs.2009.09.025.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinomaEdemaEndosonographyFemoral VeinGraft Occlusion, VascularHumansKaplan-Meier EstimateMesenteric VeinsMiddle AgedNeoplasm InvasivenessPancreatic NeoplasmsPancreaticoduodenectomyPortal VeinRegistriesReoperationSaphenous VeinTime FactorsTissue and Organ HarvestingTomography, X-Ray ComputedTreatment OutcomeUltrasonography, Doppler, DuplexVascular PatencyVascular Surgical ProceduresConceptsPV/SMV reconstructionLower extremity edemaLower extremity veinsPostoperative wound problemsLate mortalityExtremity edemaFemoral veinExtremity veinsSaphenous veinWound problemsPreoperative imagingPortal veinPV/SMV invasionSuperior mesenteric vein invasionPreoperative computed tomography (CT) imagingPV/SMVVein harvest siteLower extremity complicationsKaplan-Meier analysisGreat saphenous veinMinor operative proceduresEndoscopic ultrasound scanSuperior mesenteric vein reconstructionComputed tomography (CT) imagingPatent reconstruction